Provided by Tiger Trade Technology Pte. Ltd.

CRISPR Therapeutics AG

55.32
-0.6800-1.21%
Pre-market: 55.29-0.0300-0.05%07:51 EDT
Volume:1.17M
Turnover:65.37M
Market Cap:5.35B
PE:-11.62
High:57.11
Open:56.55
Low:55.28
Close:56.00
52wk High:78.48
52wk Low:44.12
Shares:96.69M
Float Shares:93.17M
Volume Ratio:0.75
T/O Rate:1.26%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.7595
EPS(LYR):-6.4700
ROE:-26.09%
ROA:-14.20%
PB:3.06
PE(LYR):-8.55

Loading ...

Crispr Therapeutics AG (CRSP) Receives a Hold from Wells Fargo

TIPRANKS
·
Aug 05

Crispr Therapeutics Posts "Quiet" Quarter as Casgevy Advances, SiRNA Data Readouts Near, RBC Says

MT Newswires Live
·
Aug 04

Crispr Therapeutics AG Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 04

Crispr Therapeutics Q2 FY26 Net Loss Narrows to $91.2 Million; Casgevy Revenue Rises 151% Year over Year to $76 Million

Reuters
·
Aug 04

CRISPR Therapeutics Q2 EPS $(0.94) Beats $(1.17) Estimate, Sales $10.181M Beat $6.789M Estimate

Benzinga Earnings
·
Aug 04

Scribe's Genetic Editing Aims to Prevent Heart Attacks

Dow Jones
·
Jul 30

Opening Day: Scribe Therapeutics makes strong trading debut

TIPRANKS
·
Jul 27

CRISPR Therapeutics (CRSP) Enters Phase 1 With CTX112 In Allogeneic CAR T

Simply Wall St.
·
Jul 25

CRISPR Therapeutics (CRSP) Is Down 10.4% After EPS, Revenue Expectations Diverge From Valuation Concerns

Simply Wall St.
·
Jul 18

Crispr Therapeutics Expands Autoimmune Pipeline With New CTX112 Trial

TIPRANKS
·
Jul 17

Crispr Therapeutics AG Slides Despite Bullish Wall Street

TIPRANKS
·
Jul 11

CRISPR Therapeutics: Buy Rating Reiterated as Pediatric CASGEVY Label Expands; $80 Price Target Maintained

TIPRANKS
·
Jul 08

CRISPR Gene Editing Therapy Shows Groundbreaking Efficacy in Pediatric Patients

Deep News
·
Jun 30

HCA Healthcare announces research published in NEJM on CRISPR-based therapy

TIPRANKS
·
Jun 29

Week's Best: Spacex is Changing Market Indexes. ETF Investors, Take Note.

Dow Jones
·
Jun 27

Gil Blum Reiterates Buy on CRISPR Therapeutics, Maintains $82 Price Target on Pipeline Upside and 2026 Data Catalysts

TIPRANKS
·
Jun 24

Thanks to SpaceX, Index Funds Won't Track Each Other as Closely. Here's One Pro's Advice. -- Barrons.com

Dow Jones
·
Jun 23

Nutrien, CAVA, Cracker Barrel, ADMA, CRISPR Trending With Analysts

TIPRANKS
·
Jun 13

Analysts Offer Insights on Healthcare Companies: Crispr Therapeutics AG (CRSP) and Hinge Health, Inc. Class A (HNGE)

TIPRANKS
·
Jun 11

Why CRISPR Therapeutics (CRSP) Is Down 7.7% After Major Shelf Filing and Governance Changes – And What's Next

Simply Wall St.
·
Jun 07